Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?

Prostate cancer invokes major shifts in gene transcription and metabolic signaling to mediate alterations in nutrient acquisition and metabolic substrate selection when compared to normal tissues. Exploiting such metabolic reprogramming is proposed to enable the development of targeted therapies for...

Full description

Bibliographic Details
Main Authors:	Gio Fidelito, Matthew J. Watt, Renea A. Taylor
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Oncology
Subjects:	prostate neoplasia lipid metabolism obesity metabolism patient-derived xenograft metabolic targeting
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.778761/full

Similar Items

Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer
by: Min Lu, et al.
Published: (2018-11-01)

New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
by: Vittoria Rago, et al.
Published: (2023-10-01)

Lipid metabolism, amino acid metabolism, and prostate cancer: a crucial metabolic journey
by: Lin Chen, et al.
Published: (2024-01-01)

Research Progress of Lipid Metabolism Reprogramming in Prostate Cancer
by: ZENG Kai, et al.
Published: (2022-08-01)

Precision Medicines for Retinal Lipid Metabolism-Related Pathologies
by: Raquel da Ana, et al.
Published: (2023-04-01)

Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models
by: Bora Lee, et al.
Published: (2023-12-01)

Upregulation of Succinate Dehydrogenase (SDHA) Contributes to Enhanced Bioenergetics of Ovarian Cancer Cells and Higher Sensitivity to Anti-Metabolic Agent Shikonin
by: Lin Wang, et al.
Published: (2022-10-01)

Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
by: Sofia Karkampouna, et al.
Published: (2020-12-01)

Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells
by: Pablo Sanchis, et al.
Published: (2022-04-01)

Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated
by: Alexandra McLean Stevens, et al.
Published: (2023-02-01)

Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer
by: Matthew Alberto, et al.
Published: (2023-01-01)

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A
by: Nichelle C. Whitlock, et al.
Published: (2022-10-01)

Tissue-Specific Approaches Reveal Diverse Metabolic Functions of Rho-Kinase 1
by: Taylor Landry, et al.
Published: (2021-02-01)

A Novel Indicator Of Lipid Accumulation Product Associated With Metabolic Syndrome In Chinese Children And Adolescents
by: Zhang Y, et al.
Published: (2019-10-01)

Prostate Cancer Progression: as a Matter of Fats
by: Natalia Scaglia, et al.
Published: (2021-07-01)

In Vivo Models for Prostate Cancer Research
by: Robert Adamiecki, et al.
Published: (2022-10-01)

Prospective cohort of parameters of glycemic and lipid metabolism after abdominoplasty in normal weight and formerly obese patiens
by: Leandro R.de A. Santos, et al.
Published: (2023-09-01)

Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
by: Zeyad D Nassar, et al.
Published: (2020-07-01)

The role of ABCC5 in metabolism and signalling in prostate cancer
by: Abele, J
Published: (2024)

Evaluation of the hemostatic state, carbohydrate and lipid metabolism in young women with abdominal obesity and hypertension
by: Veronika Andreevna Sumerkina, et al.
Published: (2015-12-01)

The role of lipid disbolism in kidney disease in metabolic syndrome associated with obesity
by: Aleksandra Aleksandrovna Kryachkova, et al.
Published: (2011-08-01)

Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro
by: Antonio Altuna-Coy, et al.
Published: (2021-09-01)

Improving obesity and lipid metabolism using conjugated linoleic acid
by: Ye Sun, et al.
Published: (2022-11-01)

Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development
by: Xinpei Ci, et al.
Published: (2020-06-01)

The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism
by: Qijing Fan, et al.
Published: (2021-06-01)

The effects of voluntary wheel running during weight-loss on biomarkers of hepatic lipid metabolism and inflammation in C57Bl/6J mice
by: Joshua S. Wooten, et al.
Published: (2022-01-01)

Supplementation with Low Doses of a Cod Protein Hydrolysate on Glucose Regulation and Lipid Metabolism in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study
by: Caroline Jensen, et al.
Published: (2020-07-01)

Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer
by: Mark D. Long, et al.
Published: (2021-12-01)

The Association Between Metabolic Syndrome and Prostate Cancer Risk: A Large-Scale Investigation and Study of Chinese
by: Xiaoshuai Gao, et al.
Published: (2022-05-01)

Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
by: Ergang Wang, et al.
Published: (2022-12-01)

Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
by: Cai Z, et al.
Published: (2020-07-01)

Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
by: Takeshi Namekawa, et al.
Published: (2019-01-01)

Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
by: Juan C. Pardo, et al.
Published: (2022-02-01)

The role of glutamine metabolism in castration-resistant prostate cancer
by: Bing Zhao, et al.
Published: (2023-01-01)

BONE METABOLISM AND EFFICACY OF THE ZOLEDRONIC ACID IN LOCALLY ADVANCED AND DISSEMINATED PROSTATE CANCER
by: P. V. Glybochko, et al.
Published: (2022-12-01)

The Metabolic Phenotype of Prostate Cancer
by: Eric Eidelman, et al.
Published: (2017-06-01)

Influence of Pre-Pregnancy Obesity on Carbohydrate and Lipid Metabolism with Selected Adipokines in the Maternal and Fetal Compartment
by: Andrzej Miturski, et al.
Published: (2023-04-01)

Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?
by: Bahar Arıcan Tarım, et al.
Published: (2023-09-01)

Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
by: Bei Xu, et al.
Published: (2021-10-01)

Genetic Background of Metabolically Healthy and Unhealthy Obesity Phenotypes in Hungarian Adult Sample Population
by: Peter Piko, et al.
Published: (2023-03-01)